Elizabeth DeVita-Raeburn is a New York-based writer who specializes in science, health and medicine. She is the author of The Death of Cancer and The Empty Room. She lives in New York City, with her husband, the writer Paul Raeburn, and two sons.
Elizabeth DeVita-Raeburn
From this contributor
The controversy over autism’s most common therapy
Applied behavioral analysis is the most widely used therapy for autism, but some people say its drills and routines are cruel, and its aims misguided.
The controversy over autism’s most common therapy
By
Elizabeth DeVita-Raeburn
10 August 2016 | 20 min read
Explore more from The Transmitter
Autism prevalence increasing in children, adults, according to electronic medical records
The uptick from 2011 to 2022 in the United States underscores a need for more services and research, the investigators say.
Autism prevalence increasing in children, adults, according to electronic medical records
The uptick from 2011 to 2022 in the United States underscores a need for more services and research, the investigators say.
By
Shaena Montanari
21 November 2024 | 2 min read
Immune cell interlopers breach—and repair—brain barrier in mice
The choroid plexus, the protective network of blood vessels and epithelial cells that line the brain’s ventricles, recruits neutrophils and macrophages during inflammation, a new study shows.
Immune cell interlopers breach—and repair—brain barrier in mice
The choroid plexus, the protective network of blood vessels and epithelial cells that line the brain’s ventricles, recruits neutrophils and macrophages during inflammation, a new study shows.
By
Claudia López Lloreda
20 November 2024 | 6 min read
Expanding set of viral tools targets almost any brain cell type
Harmless viruses that encase short noncoding DNA elements called enhancers enable cell-type-specific gene delivery across the central nervous system in rodents and primates.
Expanding set of viral tools targets almost any brain cell type
Harmless viruses that encase short noncoding DNA elements called enhancers enable cell-type-specific gene delivery across the central nervous system in rodents and primates.
By
Holly Barker
19 November 2024 | 2 min watch